Tag - TNDM

Developments

Tandem expands pediatric indication of insulin pump

Tandem Diabetes Care (NASDAQ:TNDM) received FDA clearance of an expanded pediatric indication for the t:slim Insulin Pump, lowering its use to children age 6 and older from children age 12 and older. The t:slim Pump is...

July 26, 2016

Feature

Tandem takes consumer device approach to insulin pumps

By Len Zehr Tandem Diabetes (NASDAQ:TNDM), which now markets the popular t:slim Insulin Pump for people with Type 1 diabetes and has two new pumps awaiting FDA clearance, has taken a unique consumer-focused approach to...

November 18, 2014

Tag - TNDM

Tandem expands pediatric indication of insulin pump

Tandem takes consumer device approach to insulin pumps

General

More